Company profile: Mologic
1.1 - Company Overview
Company description
- Provider of point-of-care diagnostic solutions, offering contract research for assay and antibody development, flexible manufacturing of lateral flow diagnostics, and a portfolio of rapid tests for health issues including yellow fever and chronic obstructive pulmonary disorder. Also partners with governments and organizations to distribute diagnostics globally, focusing on areas with significant need.
Products and services
- Rapid Diagnostic Tests: Produces clinical-grade, point-of-care rapid test products for various health issues, specifically yellow fever and chronic obstructive pulmonary disorder, supporting frontline diagnostics
- Contract Research & Development: Delivers custom-engineered contract research for point-of-care diagnostics, encompassing assay development and antibody development to architect tailored diagnostic components
- Lateral Flow Manufacturing: Fabricates industrial-grade lateral flow diagnostic assemblies with flexible production capacity, supporting both internal programs and third-party requirements
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Mologic
Fluidic
HQ: United Kingdom
Website
- Description: Provider of tools for protein characterization, designing, developing and manufacturing instruments based on Microfluidic Diffusional Sizing (MDS) to analyze protein interactions in their native conditions without immobilization, delivering data on affinity, size and concentration.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Fluidic company profile →
GlycoFi
HQ: United States
Website
- Description: Provider of biotherapeutic development based on glycan optimization technology and a yeast-based glycosylation protein manufacturing process, aiming to build its own pipeline of therapeutic proteins and partner with other drug-makers to develop products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GlycoFi company profile →
Scireq
HQ: Canada
Website
- Description: Provider of laboratory equipment for preclinical respiratory research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Scireq company profile →
ArcticZymes Technologies
HQ: Norway
Website
- Description: Provider of enzymes and kits for medical research, developed and manufactured by a biotechnology company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ArcticZymes Technologies company profile →
Altar
HQ: France
Website
- Description: Provider of biotechnology solutions in automated fluidics, developing and operating proprietary technologies that bring microbes to performance suitable for commercial use. Serves customers leveraging microorganisms to produce food, feed, flavors & fragrances, cosmetics, and fuels.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Altar company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Mologic
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Mologic
2.2 - Growth funds investing in similar companies to Mologic
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Mologic
4.2 - Public trading comparable groups for Mologic
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →